SUMMARY
BACKGROUND The SARS-CoV-2 pandemic was a major stressful event that significantly affected healthcare providers. This study aimed to compare the efficacy of a single-session intervention (SSI) with and without weekly personalized pre-recorded videos to prevent the worsening of emotional distress.
METHODS Nationwide randomized clinical trial conducted in Brazil from May 19, 2020 to December 31, 2021. We included healthcare professionals with levels of anxiety, depression, or irritability below a T-score of 70, defined by the Patient-Reported Outcomes Measurement Information System. The exclusion criterion was suicide risk. Participants were randomized to SSI or SSI plus weekly personalized pre-recorded videos for four weeks (SSI-ET). The primary outcome was the proportion of participants with a significant escalation of symptoms (i.e., T-score above 70). The trial was registered with ClinicalTrials.gov (NCT04632082).
FINDINGS Of the 3328 volunteers assessed for eligibility, 1112 participants were allocated to either SSI (n=549) or SSI-ET (n=563). The cumulative proportion of incident cases at six months was 17.5% (95% CI 13.1% to 21.6%) for SSI and 15% (95% CI 10.9% to 18.8%) for SSI-ET, with no difference between groups (HR=0.81, 95% CI 0.83 to 1.79). Both groups presented significant symptom reduction in the one-month assessment and maintained over three and six-month follow-ups (Cohen’s d range = 0.68 - 1.08).
CONCLUSIONS We found no benefit of adding asynchronous videos to SSIs; however, we found strong effects for the synchronous component for preventing symptom worsening. This component emphasizes core elements of mental health support, such as active listening, validation, and empathic care. Due to its simplicity and scalability, this intervention shows promise as a public health measure to be widely implemented.
FUNDING Ministry of Health of Brazil, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, and Fundo de Incentivo à Pesquisa/Hospital de Clínicas de Porto Alegre.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov (NCT04632082)
Funding Statement
This study was funded in part by the Ministry of Health of Brazil through, the decentralized execution term No. 16/2020, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 001), Brazilian federal government agencies, and Fundo de Incentivo a Pesquisa/Hospital de Clinicas de Porto Alegre (FIPE/HCPA, 001), Brazil.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Research Ethics Commission (CONEP) approved the trial protocol.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos